Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine

Objective Assess whether patients with chronic pain receiving 80 to 220 mg oral morphine sulfate equivalent of a full μ-opioid agonist could be transitioned to buccal buprenorphine at approximately 50% of their full dose without inducing opioid withdrawal or sacrificing analgesic efficacy. Methods. ...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Lynn, Gruener, Daniel, Kirby, Todd, Xiang, Qinfang, Tzanis, Evan, Finn, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984426/
https://www.ncbi.nlm.nih.gov/pubmed/26917621
http://dx.doi.org/10.1093/pm/pnv110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984426/
https://www.ncbi.nlm.nih.gov/pubmed/26917621
http://dx.doi.org/10.1093/pm/pnv110

Ejemplares similares